Literature DB >> 22454912

A pharmacokinetic interaction in man between phenobarbitone and fenoprofen, a new anti-inflammatory agent.

L Helleberg1, A Rubin, R L Wolen, B E Rodda, A S Ridolfo, C M Gruber.   

Abstract

1 The effect of repeated administration of phenobarbitone on the plasma disposition of fenoprofen (±-2-(3-phenoxyphenyl) propionic acid) was investigated in rats and man. 2 The plasma elimination rate constants increased significantly and the rats excreted proportionately more metabolized fenoprofen in the urine. These findings are consistent with an increase in the rate of metabolism of fenoprofen. 3 This interaction between phenobarbitone (and presumably other inducers of drug metabolizing enzymes) and fenoprofen should be considered when evaluating the clinical usefulness of fenoprofen.

Entities:  

Year:  1974        PMID: 22454912      PMCID: PMC1402462          DOI: 10.1111/j.1365-2125.1974.tb00271.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration.

Authors:  A Rubin; B E Rodda; P Warrick; A S Ridolfo; C M Gruber
Journal:  J Pharm Sci       Date:  1972-05       Impact factor: 3.534

2.  Physiological disposition of fenoprofen in man. I. Pharmacokinetic comparison of calcium and sodium salts administered orally.

Authors:  A Rubin; B E Rodda; P Warrick; A Ridolfo; C M Gruber
Journal:  J Pharm Sci       Date:  1971-12       Impact factor: 3.534

3.  Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

4.  GLC determination of dl-2-(3-phenoxyphenyl)propionic acid (Fenoprofen) in human plasma.

Authors:  J F Nash; R J Bopp; A Rubin
Journal:  J Pharm Sci       Date:  1971-07       Impact factor: 3.534

  4 in total
  6 in total

Review 1.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 2.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 3.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

4.  Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.

Authors:  R N Brogden; R M Pinder; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-04       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of drugs used in juvenile arthritis.

Authors:  K J Skeith; F Jamali
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.